Lazard, Inc. (LAZ): Entry into a Material Definitive Agreement
Lazard, Inc. (LAZ) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 Lazard Completes Its Acquisition of Campbell Lutyens and Launches Lazard CL, the Global Leader for the Next Era of Private Capital NEW YORK and LONDON, November 2, 2026 – Lazard, Inc. (NYSE: LAZ) today announced the completion of the firm’s acquisition of Campbell Lu
- Role
- acquirer
- Counterparty
- Campbell Lutyens
- Consideration
- stock
Facts are quoted from the filing text and checked against it.
How this was made
The 30-second read
Why it matters
The acquisition is positioned as a growth engine, with projected $500M revenue and earnings accretion in 2027, suggesting a positive market reaction.
Market read
First disclosure of a major acquisition for a large financial services firm, likely to move the stock and influence the advisory sector.
What to watch
Lock‑up provisions on Lazard stock used for consideration may limit immediate upside for shareholders
Background
SEC Form 8‑K filing reports Lazard's entry into a material definitive agreement, completing the acquisition of Campbell Lutyens and launching Lazard CL.
Ticker impact
Lazard announced completion of its acquisition of Campbell Lutyens, creating Lazard CL and projecting $500M combined revenue, accretive to 2027 earnings.
likely upward pressure as investors price in accretive earnings and revenue growth
A large, strategic acquisition with clear revenue guidance typically lifts the acquirer's stock on the day of filing.
Market effects
strengthens Lazard's position in private capital advisory, pressuring peers in the boutique investment banking space
enhances Lazard's footprint across North America, Europe, Middle East and Asia-Pacific
adds to consolidation trend in financial advisory services worldwide
Counterpoint
Integration risks and potential cultural clashes could delay synergies, weighing on short-term performance
Key entities
- companyLazard, Inc.
Acquirer, listed on NYSE under LAZ
- companyCampbell Lutyens
Target of the acquisition, now part of Lazard CL



